HANNA; Mazen
Patent Applications and Registrations
Patent applications and USPTO patent grants for HANNA; Mazen.The latest application filed is for "novel ternary molecular complex of tamibarotene for cancer stem cells treatment".
Company Profile
10.31.31
- HANNA; Mazen - Tampa FL
- Hanna; Mazen - Lutz FL
- Hanna; Mazen - Bradford N/A GB
- Hanna; Mazen - Leeds GB3
Patent Activity
| Patent | Date |
|---|---|
| Novel Ternary Molecular Complex Of Tamibarotene For Cancer Stem Cells Treatment App 20220185767 - HANNA; Mazen ; et al. | 2022-06-16 |
| Crystalline forms of Actinomycin D for treatment of cancer Grant 11,319,311 - Hanna , et al. May 3, 2 | 2022-05-03 |
| Crystalline forms of mitomycin C for treatment of cancer Grant 11,053,254 - Hanna , et al. July 6, 2 | 2021-07-06 |
| Novel Crystalline Forms Of Actinomycin D For Treatment Of Cancer App 20210053963 - HANNA; Mazen ; et al. | 2021-02-25 |
| Novel Crystalline Forms Of Tamibarotene For Treatment Of Cancer App 20210002209 - HANNA; Mazen ; et al. | 2021-01-07 |
| Molecular Engineering Of A Novel Ternary Complex Of Actinomycin D For Cancer Stem Cells Treatment App 20200323949 - HANNA; Mazen ; et al. | 2020-10-15 |
| Crystalline forms Grant 10,526,358 - Hanna , et al. J | 2020-01-07 |
| Crystalline forms Grant 10,519,176 - Hanna , et al. Dec | 2019-12-31 |
| Methods For Cancer Stem Cell (csc) Expansion App 20190292524 - NAIR; Rajesh ; et al. | 2019-09-26 |
| Novel Crystalline Forms Of Mitomycin C For Treatment Of Cancer App 20190248800 - HANNA; Mazen ; et al. | 2019-08-15 |
| Crystallization method and bioavailability Grant 10,323,052 - Hanna , et al. | 2019-06-18 |
| Novel Crystalline Forms App 20190144474 - HANNA; Mazen ; et al. | 2019-05-16 |
| Crystallization Method And Bioavailability App 20190083407 - HANNA; Mazen | 2019-03-21 |
| Crystallization method and bioavailability Grant 10,195,218 - Hanna Fe | 2019-02-05 |
| Novel Crystalline Forms App 20190002483 - HANNA; Mazen ; et al. | 2019-01-03 |
| Crystallization Method And Bioavailability App 20180333425 - HANNA; Mazen ; et al. | 2018-11-22 |
| Crystallization method and bioavailability Grant 10,093,691 - Hanna , et al. October 9, 2 | 2018-10-09 |
| Crystallization Method And Bioavailability App 20180000847 - HANNA; Mazen | 2018-01-04 |
| Oral forms of a phosphonic acid derivative Grant 9,682,091 - Hanna , et al. June 20, 2 | 2017-06-20 |
| Crystallization Method And Bioavailability App 20170022226 - HANNA; Mazen ; et al. | 2017-01-26 |
| Crystallization Method And Bioavailability App 20170022227 - HANNA; Mazen ; et al. | 2017-01-26 |
| Novel Crystalline Forms App 20170022225 - HANNA; Mazen ; et al. | 2017-01-26 |
| Crystalline forms Grant 9,340,565 - Hanna , et al. May 17, 2 | 2016-05-17 |
| Crystallization method and bioavailability Grant 9,334,296 - Hanna , et al. May 10, 2 | 2016-05-10 |
| Crystallization Method And Bioavailability App 20160016982 - HANNA; Mazen ; et al. | 2016-01-21 |
| Novel Oral Forms Of A Phosphonic Acid Derivative App 20150306116 - HANNA; Mazen ; et al. | 2015-10-29 |
| Crystallization method and bioavailability Grant 9,169,279 - Hanna , et al. October 27, 2 | 2015-10-27 |
| Crystalline molecular comlpexes of tadalafil Grant 9,040,535 - Hanna , et al. May 26, 2 | 2015-05-26 |
| Oral forms of a phosphonic acid derivative Grant 8,980,868 - Hanna , et al. March 17, 2 | 2015-03-17 |
| Crystallization method and bioavailability Grant 8,933,057 - Hanna , et al. January 13, 2 | 2015-01-13 |
| Crystallization Method And Bioavailability App 20140107076 - HANNA; Mazen ; et al. | 2014-04-17 |
| Crystalization Of Pharmaceutical Compounds App 20140100233 - HANNA; Mazen ; et al. | 2014-04-10 |
| Crystallization Method And Bioavailability App 20140057875 - HANNA; Mazen ; et al. | 2014-02-27 |
| Novel Crystalline Forms App 20130316982 - Hanna; Mazen ; et al. | 2013-11-28 |
| Crystalline molecular complex of tadalafil and methylparaben Grant 8,586,587 - Hanna , et al. November 19, 2 | 2013-11-19 |
| Crystalline forms of lamotrigine Grant 8,486,927 - Hanna , et al. July 16, 2 | 2013-07-16 |
| Crystallization method and bioavailability Grant 8,399,023 - Hanna , et al. March 19, 2 | 2013-03-19 |
| In vivo studies of crystalline forms of meloxicam Grant 8,389,512 - Hanna , et al. March 5, 2 | 2013-03-05 |
| Crystallization Method And Bioavailability App 20130035315 - HANNA; Mazen ; et al. | 2013-02-07 |
| Method of creating crystalline substances Grant 8,241,371 - Hanna , et al. August 14, 2 | 2012-08-14 |
| Novel Oral Forms Of A Phosphonic Acid Derivative App 20120190647 - Hanna; Mazen ; et al. | 2012-07-26 |
| In Vivo Studies of Crystalline Forms of Meloxicam App 20120149692 - Hanna; Mazen ; et al. | 2012-06-14 |
| In vivo studies of crystalline forms of meloxicam Grant 8,124,603 - Hanna , et al. February 28, 2 | 2012-02-28 |
| Crystalization Of Pharmaceutical Compounds App 20120046297 - Hanna; Mazen ; et al. | 2012-02-23 |
| Crystallization Method And Bioavailability App 20110028435 - HANNA; Mazen ; et al. | 2011-02-03 |
| In vivo studies of crystalline forms of meloxicam App 20090203680 - Hanna; Mazen ; et al. | 2009-08-13 |
| Crystalline Forms of lamotrigine App 20090176787 - Hanna; Mazen ; et al. | 2009-07-09 |
| Method Of Creating Crystalline Substances App 20080280858 - Hanna; Mazen ; et al. | 2008-11-13 |
| Method and apparatus for the formation of particles App 20030047824 - Hanna, Mazen ; et al. | 2003-03-13 |
| Method and apparatus for the formation of particles Grant 6,440,337 - Hanna , et al. August 27, 2 | 2002-08-27 |
| Method and apparatus for the formation of particles Grant 6,063,138 - Hanna , et al. May 16, 2 | 2000-05-16 |
| Method and apparatus for the formation of particles Grant 5,851,453 - Hanna , et al. December 22, 1 | 1998-12-22 |
| Salmeterol xinafoate with controlled particle size Grant 5,795,594 - York , et al. August 18, 1 | 1998-08-18 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 